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The Exercise Echocardiographic Profile of 
Healthy Post Menopausal Women
Vijay K. Guiati, James M. Hagberg, Steve D. McCole, John Gorcsan 
University of Pittsburgh, Pittsburgh, PA
The dynamic cardiac response to upright exercise has not been well charac­
terized in healthy post-menopausal women. Accordingly, 20 such volunteers, 
aged 64 ±  6  yrs, underwent serial echocardiographic study of LV volumes 
by modified Simpson’s rule at rest and during each stage of upright bicycle 
exercise. Work rate was increased by 15 W every 3 min until exhaustion. 
Peak work rate ranged from 45 to 105 W. As expected, progressive increases 
in cardiac output (CO) occurred with exercise. Seventy-six % of this increase 
was attributed to increases in heart rate and 24% to increases in stroke 
volume (SV), p < 0.05, rest vs. 30 W and 30 vs. 90 W). Augmentation in 
SV was associated with significant progressive increases in end-diastolic 
volume (p < 0.05, rest vs. 45 W and 45 vs. 90 W) as end-systolic volume 
was unchanged. LV ejection fraction rose slightly from group mean of 67% 
at rest to 75% at 105 W (p < 0.01).
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Conclusions: The cardiac response to upright exercise in healthy post­
menopausal women may be characterized by progressive increases in end- 
diastolic volume, heart rate, SV, CO, and ejection fraction. These data may 
be clinically useful to identify an abnormal cardiac exercise response in 
post-menopausal pts with heart disease.
Exercise Testing for the Evaluation of 
Lipid-Lowering Therapy. Functional Assessment 
Versus Quantitative Coronary Angiography in the 
Low-Density-Lipoprotein Apheresis 
Atherosclerosis Regression Study
Wim R. Aengevaeren, Abraham A. Kroon, Tjeerd van der Werf, Gerard 
J. Uijen, Anton F. Stalenhoef. Departments of Cardiology and General 
Internal Medicine, University Hospital Nijmegen, The Netherlands
In patients with coronary artery disease (CAD) exercise testing is used for 
evaluation of PTCA, CABG and anti-anginal drug therapy. Little information 
is available about the potential of exercise testing for the evaluation of lipid- 
lowering therapy.
Method: We studied 42 patients with familial hypercholesterolemia and 
extensive CAD who were randomized to diet and simvastatin with or without 
biweekly LDL-apheresis. LDL-apheresis was performed over dextran sul­
phate columns. Biclyde exercise testing was performed under standardized 
conditions at baseline (base), after 1 and 2 years of therapy. The final exercise 
test was performed 1 month after the last LDL-apheresis to avoid possible 
short term effects on blood rheology. Mean segment diameter (MSD) and 
minimal obstruction diameter (MOD) were assessed by QCA,
Resuits; LDL-cholesterol decreased from 7.72 ±  1.96 mmoi/l to a time 
averaged level of 2.95 ±  1.13 (-63% ) in the LDL-apheresis (L) group and 
from 7.85 ±  2.34 mmol/l to 4.13 ±  1,58 mmoi/l (-43%) In the medication (M) 
group, difference in response p < 0 .0 1 .
Exercise LDL-apheresis Medication
testing base 1 year 2 years base 1 year 2 years
ST-time (s) 
ST-max (mm)
461 ±47 548 ±51 
1.4 ±0.2 0.8 ±0.2
641 ±50* 
0.7 ±0.2*
485 ± 81 
1.4 ±0.3
464 ± 54 
1.3 ± 0.4
442 ± 60 
1.4±0.4
ST-time, time to 1 mm (- 0.1 mV) ST-depressian; ST-max, maximal ST depression; 
^difference between L and M group p < 0.01. QCA revealed no difference in coronary 
anatomy.
Conclusions: Exercise parameters improved only in the LDL-apheresis 
group along with a pronouced reduction in LDL-cholesterol but without 
change in coronary anatomy. Exercise testing, a functional test of the coro­
nary circulation, has to be considered as a valuable inexpensive tool for the 
evaluation of lipid-lowering therapy in patients with myocardial ischemia.
Elevated Intramuscular Diprotonated Pi (H2 PO4“) 
During Exercise in Patients With Chronic Heart 
Failure
Michael Welsch, Heidi Kluess, William Brechue, Ray Ballinger,
Katherine Scott, Michael Pollock, Carl J. Pepine. Div. of Cardiovascular 
Med., Center for Exercise Science., Univ. of Florida and the VAMC, 
Gainesville, FL
We have shown that metaboiic downregulation may depress muscle function 
in chronic heart failure (HF). This study examined muscle energetics in 10 
HF pts (age: 58 ±  5 yrs, EF < 40% ±  10, NYHA II—Hi) and 10 controls 
(CON) (age: 62 ±  4 yrs) during low (LO; 25% MVC) and high (HI; 85% MVC) 
intensity calf flexion exercise (1 contract/4 s). From an RF coil positioned 
over the medial gastroc head continuous spectra were collected (32 s time 
resolution). LO was terminated at 1 0  min and resulted in a decrease in [PCrJ 
(HF: 38.75 ±  0.76 to 20.46 ±  1.95 mM, CON: 38.01 ±  0.73 to 27.75 ±  2.74 
mM) and pH (HF: 7.09 ±  0.04 to 6.91 ±  0.05, CON: 7.05 ±  0.05 to 7.04 ±  
0.08), and an increase in [Pi] (HF: 5.51 ±  0,57 to 16.12 ±  1.47 mM, CON: 
5.15 ±  0.46 to 13.41 ±  1.67 mM). HI was terminated at exhaustion (HF: 4:00, 
CON: 4:25) resulting in greater changes in [PCr] (HF: 37.78 ±  1.04 to 12.79 
±  2.64 mM, CON: 38.43 ±  0.78 to 12.89 ±  1.68 mM) and pH (HF: 7.11 ±  
0.10  to 6.65 ±  0.19, CON:7.09 ±  0.02 to 6.90 ±  0.08), and an increase in [Pi] 
(HF: 4.96 ±  0.41 to 20.42 ±  1 .95 mM, CON: 4.99 ±  0.62 to 19.61 ±  1.06 mM) 
compared to LI. [ATP] remained unchanged during both conditions. Exercise 
was associated with a greater decline in pH (LO&HI) and increase in [Pi] 
(LO) in HF. This resulted in more H2 PO4  in HF compared to CON (LO;HF: 
275% ±  51, CON: 101% ±  20; HI:HF: 740% ±  192, CON: 441 % ±  43) (p <
0.05). This increase in H2 PO4  may be associated with reduced contractile 
function by altering cross-bridge kinetics and may contribute to the marked 
exercise limitations in HF.
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1006-15 Apoptosis of Human Endothelial Cells Is Induced 
Synergistically by Ox-LDL and TNFa; Attenuation 
by 17/3-Estradiol
René J. Alvarez Jr., Arthur T. Hoang, Emily E. Miliiken, SanfJrd J. Gips, Chi. 
V. Dang, Pascal J. Goidschmidt-Clermont. Johns Hopkins Hospital, 
Baltimore, MD
Endothelial cell (EC) dysfunction, increased cell turnover and apoptosis have 
been implicated in the promotion and progression of atherosclerosis. Estro­
gen metabolites have been shown to be potent anti-atherogenic agents, 
although the mechanism of protection has not been completely defined. 
In other systems, TNFa and oxidized-LDL (ox-LDL) have been shown to be 
strong inducers of apoptosis. We have evidence that the estrogen metabolite, 
170-estradiol (EST), reduces EC apoptosis induced by ox-LDL and TNFa. 
We sought to further characterize the effect of 170-estradiol on EC apoptosis.
Human EC were cultured in the presence or absence of varying concen­
trations of non-oxidized LDL (LDL) and ox-LDL with or without 50 mg/L of 
TNFa. Morphology of the cells was studied by phase microscopy and apopto­
sis was determined by FACS analysis of digoxigenin-labelled genomic DNA 
fragments (TUNEL assay).
TNFa (50 mg/L) and ox-LDL (50 mg/L) in combination lead to morphologic 
changes consistent with apoptosis: retraction of the EC cells, loss of adhesion 
to the substratum, and membrane blebbing. When ceils were analyzed after 
72 hrs by TUNEL, TNFa (50 mg/L) and ox-LDL (50 mg/L) alone lead to 
apoptosis of EC in 15% and 14% of cells, respectively. However, co-culture 
of EC with ox-LDL (50 mg/L) and TNFa (50 mg/L) resulted in apoptosis 
of 55% of the EC. The apoptosis induced by the combination of 50 mg/L 
ox-LDL and 50 mg/L TNFa was attenuated by 39% with pre-treatment of the 
cells with 10“ 8  M 170-estradiol. LDL did not induce apoptosis of EC in the 
presence or absence of TNFa.
Thus, we conclude that TNFa and ox-LDL seem to act synergistically to
induce apoptosis in EC. The process of apoptosis is attenuated by 170-
estradiol and may account for some of the anti-atherogenic properties of 
estrogens.
